Answers are grounded in this paper and cite their sources.
Enoxaparin, a form of low-molecular-weight heparin, can cause a rare, underreported, and often reversible form of hepatocellular injury. This report describes a case of enoxaparin-induced hepatotoxicity in a 61-year-old male diagnosed with pulmonary embolism. Elevations of liver enzymes were noted within 1 week of starting the drug, followed by a dramatic improvement upon its discontinuation, with subsequent normalization in the following days.
No takes yet. Share an insight, caveat, or question.
Mehershahi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: